カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のスプリット・インフルエンザ・ワクチン市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Split Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM8061）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM8061
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のスプリット・インフルエンザ・ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のスプリット・インフルエンザ・ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のスプリット・インフルエンザ・ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- スプリット・インフルエンザ・ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

スプリット・インフルエンザ・ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・アルダート、チャイルド

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Sanofi Pasteur、CSL Seqirus、GSK、Seqirus, Inc.、straZeneca、Dalian Yali Peak

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、スプリット・インフルエンザ・ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なスプリット・インフルエンザ・ワクチンメーカーの企業概要、2019年～2022年までのスプリット・インフルエンザ・ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なスプリット・インフルエンザ・ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別スプリット・インフルエンザ・ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのスプリット・インフルエンザ・ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのスプリット・インフルエンザ・ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびスプリット・インフルエンザ・ワクチンの産業チェーンを掲載しています。
・第14、15章では、スプリット・インフルエンザ・ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– スプリット・インフルエンザ・ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：アルダート、チャイルド
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のスプリット・インフルエンザ・ワクチン市場規模・予測
– 世界のスプリット・インフルエンザ・ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi Pasteur、CSL Seqirus、GSK、Seqirus, Inc.、straZeneca、Dalian Yali Peak
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：アルダート、チャイルド
・用途別分析2018年-2029年：病院、診療所
・スプリット・インフルエンザ・ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・スプリット・インフルエンザ・ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・スプリット・インフルエンザ・ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・スプリット・インフルエンザ・ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・スプリット・インフルエンザ・ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Split Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Split Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Aldult
1.3.3 Child
1.4 Market Analysis by Application
1.4.1 Overview: Global Split Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Split Influenza Vaccine Market Size & Forecast
1.5.1 Global Split Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Split Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Split Influenza Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Split Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL Seqirus
2.2.1 CSL Seqirus Details
2.2.2 CSL Seqirus Major Business
2.2.3 CSL Seqirus Split Influenza Vaccine Product and Services
2.2.4 CSL Seqirus Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Seqirus Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Split Influenza Vaccine Product and Services
2.3.4 GSK Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Seqirus, Inc.
2.4.1 Seqirus, Inc. Details
2.4.2 Seqirus, Inc. Major Business
2.4.3 Seqirus, Inc. Split Influenza Vaccine Product and Services
2.4.4 Seqirus, Inc. Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Seqirus, Inc. Recent Developments/Updates
2.5 straZeneca
2.5.1 straZeneca Details
2.5.2 straZeneca Major Business
2.5.3 straZeneca Split Influenza Vaccine Product and Services
2.5.4 straZeneca Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 straZeneca Recent Developments/Updates
2.6 Dalian Yali Peak
2.6.1 Dalian Yali Peak Details
2.6.2 Dalian Yali Peak Major Business
2.6.3 Dalian Yali Peak Split Influenza Vaccine Product and Services
2.6.4 Dalian Yali Peak Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dalian Yali Peak Recent Developments/Updates
3 Competitive Environment: Split Influenza Vaccine by Manufacturer
3.1 Global Split Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Split Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Split Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Split Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Split Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Split Influenza Vaccine Manufacturer Market Share in 2022
3.5 Split Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Split Influenza Vaccine Market: Region Footprint
3.5.2 Split Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Split Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Split Influenza Vaccine Market Size by Region
4.1.1 Global Split Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Split Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Split Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Split Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Split Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Split Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Split Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Split Influenza Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Split Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Split Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Split Influenza Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Split Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Split Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Split Influenza Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Split Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Split Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Split Influenza Vaccine Market Size by Country
7.3.1 North America Split Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Split Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Split Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Split Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Split Influenza Vaccine Market Size by Country
8.3.1 Europe Split Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Split Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Split Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Split Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Split Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Split Influenza Vaccine Market Size by Country
10.3.1 South America Split Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Split Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Split Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Split Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Split Influenza Vaccine Market Drivers
12.2 Split Influenza Vaccine Market Restraints
12.3 Split Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Split Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Split Influenza Vaccine
13.3 Split Influenza Vaccine Production Process
13.4 Split Influenza Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Split Influenza Vaccine Typical Distributors
14.3 Split Influenza Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Split Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Split Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Split Influenza Vaccine Product and Services
Table 6. Sanofi Pasteur Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. CSL Seqirus Basic Information, Manufacturing Base and Competitors
Table 9. CSL Seqirus Major Business
Table 10. CSL Seqirus Split Influenza Vaccine Product and Services
Table 11. CSL Seqirus Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Seqirus Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Split Influenza Vaccine Product and Services
Table 16. GSK Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Seqirus, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Seqirus, Inc. Major Business
Table 20. Seqirus, Inc. Split Influenza Vaccine Product and Services
Table 21. Seqirus, Inc. Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Seqirus, Inc. Recent Developments/Updates
Table 23. straZeneca Basic Information, Manufacturing Base and Competitors
Table 24. straZeneca Major Business
Table 25. straZeneca Split Influenza Vaccine Product and Services
Table 26. straZeneca Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. straZeneca Recent Developments/Updates
Table 28. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
Table 29. Dalian Yali Peak Major Business
Table 30. Dalian Yali Peak Split Influenza Vaccine Product and Services
Table 31. Dalian Yali Peak Split Influenza Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Dalian Yali Peak Recent Developments/Updates
Table 33. Global Split Influenza Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Split Influenza Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Split Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Split Influenza Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Split Influenza Vaccine Production Site of Key Manufacturer
Table 38. Split Influenza Vaccine Market: Company Product Type Footprint
Table 39. Split Influenza Vaccine Market: Company Product Application Footprint
Table 40. Split Influenza Vaccine New Market Entrants and Barriers to Market Entry
Table 41. Split Influenza Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Split Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Split Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Split Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Split Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Split Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Split Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Split Influenza Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Split Influenza Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Split Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Split Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Split Influenza Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Split Influenza Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Split Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Split Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Split Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Split Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Split Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Split Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Split Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Split Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Split Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Split Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Split Influenza Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Split Influenza Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Split Influenza Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Split Influenza Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Split Influenza Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Split Influenza Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Split Influenza Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Split Influenza Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Split Influenza Vaccine Raw Material
Table 101. Key Manufacturers of Split Influenza Vaccine Raw Materials
Table 102. Split Influenza Vaccine Typical Distributors
Table 103. Split Influenza Vaccine Typical Customers
List of Figures
Figure 1. Split Influenza Vaccine Picture
Figure 2. Global Split Influenza Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Split Influenza Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Aldult Examples
Figure 5. Child Examples
Figure 6. Global Split Influenza Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Split Influenza Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Split Influenza Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Split Influenza Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Split Influenza Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Split Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Split Influenza Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Split Influenza Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Split Influenza Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Split Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Split Influenza Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Split Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Split Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Split Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Split Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Split Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Split Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Split Influenza Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Split Influenza Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Split Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Split Influenza Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Split Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Split Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Split Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Split Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Split Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Split Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Split Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Split Influenza Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Split Influenza Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Split Influenza Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Split Influenza Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Split Influenza Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Split Influenza Vaccine Market Drivers
Figure 73. Split Influenza Vaccine Market Restraints
Figure 74. Split Influenza Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Split Influenza Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Split Influenza Vaccine
Figure 78. Split Influenza Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のスプリット・フランジ・ベアリング市場2023年：企業・地域・タイプ・用途別分析
  • バイオディフェンスのグローバル市場（～2030年）：炭疽菌、ボツリヌス菌、コレラ菌、インフルエンザ、その他
  • 感染症治療薬のグローバル市場2023-2030：HIV、肝炎、インフルエンザ、結核、マラリア、HPV
  • 経口抗ウィルス薬のグローバル市場（2021-2031）：肝炎、ヒト免疫不全ウイルス（HIV）、インフルエンザ、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM8061 )"世界のスプリット・インフルエンザ・ワクチン市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Split Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。